• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

右心室肥厚向衰竭转变过程中的动态 microRNA 表达。

Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure.

机构信息

Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA.

出版信息

Physiol Genomics. 2012 May 1;44(10):562-75. doi: 10.1152/physiolgenomics.00163.2011. Epub 2012 Mar 27.

DOI:10.1152/physiolgenomics.00163.2011
PMID:22454450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3426410/
Abstract

MicroRNAs (miRs) are small, noncoding RNAs that are emerging as crucial regulators of cardiac remodeling in left ventricular hypertrophy (LVH) and failure (LVF). However, there are no data on their role in right ventricular hypertrophy (RVH) and failure (RVF). This is a critical question given that the RV is uniquely at risk in patients with congenital right-sided obstructive lesions and in those with systemic RVs. We have developed a murine model of RVH and RVF using pulmonary artery constriction (PAC). miR microarray analysis of RV from PAC vs. control demonstrates altered miR expression with gene targets associated with cardiomyocyte survival and growth during hypertrophy (miR 199a-3p) and reactivation of the fetal gene program during heart failure (miR-208b). The transition from hypertrophy to heart failure is characterized by apoptosis and fibrosis (miRs-34, 21, 1). Most are similar to LVH/LVF. However, there are several key differences between RV and LV: four miRs (34a, 28, 148a, and 93) were upregulated in RVH/RVF that are downregulated or unchanged in LVH/LVF. Furthermore, there is a corresponding downregulation of their putative target genes involving cell survival, proliferation, metabolism, extracellular matrix turnover, and impaired proteosomal function. The current study demonstrates, for the first time, alterations in miRs during the process of RV remodeling and the gene regulatory pathways leading to RVH and RVF. Many of these alterations are similar to those in the afterload-stressed LV. miRs differentially regulated between the RV and LV may contribute to the RVs increased susceptibility to heart failure.

摘要

微小 RNA(miRs)是一类新出现的小非编码 RNA,它们在左心室肥厚(LVH)和衰竭(LVF)中的心脏重构中起着至关重要的调节作用。然而,关于它们在右心室肥厚(RVH)和衰竭(RVF)中的作用,还没有数据。考虑到右心室在先天性右心阻塞性病变患者和全身性右心室患者中具有独特的风险,这是一个关键问题。我们使用肺动脉缩窄(PAC)建立了右心室肥厚和衰竭的小鼠模型。PAC 与对照 RV 的 miR 微阵列分析显示,miR 表达发生改变,与肥厚过程中的心肌细胞存活和生长相关的基因靶点(miR 199a-3p)和心力衰竭期间胎儿基因程序的再激活(miR-208b)有关。从肥厚到心力衰竭的转变以凋亡和纤维化(miRs-34、21、1)为特征。大多数与 LVH/LVF 相似。然而,RV 和 LV 之间存在几个关键差异:在 RVH/RVF 中上调的四个 miR(34a、28、148a 和 93)在 LVH/LVF 中下调或不变。此外,其假定的靶基因涉及细胞存活、增殖、代谢、细胞外基质周转和受损蛋白酶体功能的相应下调。本研究首次证明了 RV 重构过程中 miR 的变化以及导致 RVH 和 RVF 的基因调控途径。这些改变中的许多与负荷后 LV 的改变相似。RV 和 LV 之间差异调节的 miR 可能导致 RV 对心力衰竭的易感性增加。

相似文献

1
Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure.右心室肥厚向衰竭转变过程中的动态 microRNA 表达。
Physiol Genomics. 2012 May 1;44(10):562-75. doi: 10.1152/physiolgenomics.00163.2011. Epub 2012 Mar 27.
2
Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure.右心室肥厚和衰竭中的泛素-蛋白酶体信号改变。
Am J Physiol Heart Circ Physiol. 2013 Aug 15;305(4):H551-62. doi: 10.1152/ajpheart.00771.2012. Epub 2013 May 31.
3
Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease.分析 miRNA 特征驱动先天性心脏病绵羊模型适应性右心室肥厚
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H847-H854. doi: 10.1152/ajpheart.00057.2018. Epub 2018 Jun 15.
4
MicroRNA-34a-Dependent Attenuation of Angiogenesis in Right Ventricular Failure.微小RNA-34a依赖的右心室衰竭时血管生成减弱
J Am Heart Assoc. 2024 Feb 6;13(3):e029427. doi: 10.1161/JAHA.123.029427. Epub 2024 Jan 31.
5
MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.在肺动脉高压的Sugen5416/低氧/常氧模型的右心室中,微小RNA-140水平升高,而线粒体融合蛋白-1表达下调。
Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H689-98. doi: 10.1152/ajpheart.00264.2016. Epub 2016 Jul 15.
6
Does Cell-Type-Specific Silencing of Monoamine Oxidase B Interfere with the Development of Right Ventricle (RV) Hypertrophy or Right Ventricle Failure in Pulmonary Hypertension?单胺氧化酶 B 的细胞类型特异性沉默是否会干扰肺动脉高压中的右心室(RV)肥大或 RV 衰竭的发展?
Int J Mol Sci. 2024 Jun 5;25(11):6212. doi: 10.3390/ijms25116212.
7
Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.慢性重度肺动脉高压右心衰竭方案的分子特征。
Am J Respir Cell Mol Biol. 2011 Dec;45(6):1239-47. doi: 10.1165/rcmb.2010-0412OC. Epub 2011 Jun 30.
8
Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.肺动脉高压大鼠右心室心肌中信号分子和基质金属蛋白酶的激活
Pathol Res Pract. 2007;203(12):863-72. doi: 10.1016/j.prp.2007.08.006. Epub 2007 Oct 29.
9
Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction.在慢性流出道梗阻的小鼠模型中鉴定右心富集基因。
J Mol Cell Cardiol. 2010 Oct;49(4):598-605. doi: 10.1016/j.yjmcc.2010.07.014. Epub 2010 Jul 27.
10
Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.费希尔大鼠在严重肺动脉高压时表现出适应性不良的结构和分子右心室重构:一种易患右心衰竭的遗传性模型。
Cardiovasc Res. 2019 Mar 15;115(4):788-799. doi: 10.1093/cvr/cvy258.

引用本文的文献

1
Epigenetic Mechanisms in Heart Diseases.心脏病中的表观遗传机制
Rev Cardiovasc Med. 2025 Jul 30;26(7):38696. doi: 10.31083/RCM38696. eCollection 2025 Jul.
2
New insights into the cardio-renal benefits of SGLT2 inhibitors and the coordinated role of miR-30 family.钠-葡萄糖协同转运蛋白2抑制剂对心肾的益处及miR-30家族协同作用的新见解。
Genes Dis. 2023 Nov 23;11(6):101174. doi: 10.1016/j.gendis.2023.101174. eCollection 2024 Nov.
3
Unlocking the Potential: Angiotensin Receptor Neprilysin and Sodium Glucose Co-Transporter 2 Inhibitors for Right Ventricle Dysfunction in Heart Failure.解锁潜能:血管紧张素受体脑啡肽酶抑制剂和钠-葡萄糖共转运蛋白 2 抑制剂治疗心力衰竭右心室功能障碍。
Medicina (Kaunas). 2024 Jul 9;60(7):1112. doi: 10.3390/medicina60071112.
4
Posttranscriptional Regulation by Proteins and Noncoding RNAs.蛋白质和非编码 RNA 的转录后调控。
Adv Exp Med Biol. 2024;1441:313-339. doi: 10.1007/978-3-031-44087-8_17.
5
MicroRNA-34a-Dependent Attenuation of Angiogenesis in Right Ventricular Failure.微小RNA-34a依赖的右心室衰竭时血管生成减弱
J Am Heart Assoc. 2024 Feb 6;13(3):e029427. doi: 10.1161/JAHA.123.029427. Epub 2024 Jan 31.
6
Transcriptome studies of congenital heart diseases: identifying current gaps and therapeutic frontiers.先天性心脏病的转录组研究:识别当前差距与治疗前沿
Front Genet. 2023 Dec 13;14:1278747. doi: 10.3389/fgene.2023.1278747. eCollection 2023.
7
Right Ventricle and Epigenetics: A Systematic Review.右心室与表观遗传学:系统综述。
Cells. 2023 Nov 23;12(23):2693. doi: 10.3390/cells12232693.
8
Alternative polyadenylation regulation in cardiac development and cardiovascular disease.可变多聚腺苷酸化调控在心脏发育和心血管疾病中的作用。
Cardiovasc Res. 2023 Jun 13;119(6):1324-1335. doi: 10.1093/cvr/cvad014.
9
Upregulation of miR-335-5p Contributes to Right Ventricular Remodeling via Calumenin in Pulmonary Arterial Hypertension.miR-335-5p 的上调通过钙网蛋白促进肺动脉高压右心室重构。
Biomed Res Int. 2022 Oct 4;2022:9294148. doi: 10.1155/2022/9294148. eCollection 2022.
10
The complement C3-complement factor D-C3a receptor signalling axis regulates cardiac remodelling in right ventricular failure.补体 C3-补体因子 D-C3a 受体信号轴调节右心衰竭中的心脏重构。
Nat Commun. 2022 Sep 15;13(1):5409. doi: 10.1038/s41467-022-33152-9.

本文引用的文献

1
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.miR-29 家族:基因组学、细胞生物学及与肾和心血管损伤的相关性。
Physiol Genomics. 2012 Feb 27;44(4):237-44. doi: 10.1152/physiolgenomics.00141.2011. Epub 2012 Jan 3.
2
Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy.βIIPKC 的药理学抑制在晚期肥大中具有心脏保护作用。
J Mol Cell Cardiol. 2011 Dec;51(6):980-7. doi: 10.1016/j.yjmcc.2011.08.025. Epub 2011 Sep 2.
3
miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study.在坦佩雷血管研究中,miR-21、miR-210、miR-34a 和 miR-146a/b 在人动脉粥样硬化斑块中上调。
Atherosclerosis. 2011 Nov;219(1):211-7. doi: 10.1016/j.atherosclerosis.2011.07.020. Epub 2011 Jul 22.
4
down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4.微小 RNA-143/145 对 Kruppel 样因子-4(KLF4)的下调调控对于转化生长因子-β和骨形态发生蛋白 4 对血管平滑肌细胞表型的调节至关重要。
J Biol Chem. 2011 Aug 12;286(32):28097-110. doi: 10.1074/jbc.M111.236950. Epub 2011 Jun 13.
5
Apoptosis and the target genes of microRNA-21.细胞凋亡与微小RNA-21的靶基因
Chin J Cancer. 2011 Jun;30(6):371-80. doi: 10.5732/cjc.011.10132.
6
PPARα is regulated by miR-21 and miR-27b in human liver.过氧化物酶体增殖物激活受体α(PPARα)在人肝脏中受 miR-21 和 miR-27b 的调控。
Pharm Res. 2011 Oct;28(10):2467-76. doi: 10.1007/s11095-011-0473-y. Epub 2011 May 12.
7
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome.MicroRNA 谱分析显示,miR-21、miR486 和 miR-214 上调,并参与 Sézary 综合征中的细胞存活。
Cell Death Dis. 2011 Apr 28;2(4):e151. doi: 10.1038/cddis.2011.32.
8
MicroRNAs in the cardiovascular system.心血管系统中的 microRNAs。
Curr Opin Cardiol. 2011 May;26(3):181-9. doi: 10.1097/HCO.0b013e328345983d.
9
Regulation of cardiac microRNAs by serum response factor.血清反应因子对心脏 microRNAs 的调控。
J Biomed Sci. 2011 Feb 8;18(1):15. doi: 10.1186/1423-0127-18-15.
10
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.微小 RNA miR-34a 通过直接抑制 CD44 抑制前列腺癌干细胞和转移。
Nat Med. 2011 Feb;17(2):211-5. doi: 10.1038/nm.2284. Epub 2011 Jan 16.